Cost-Effectiveness of Apomorphine Sublingual Film as an “On-Demand” Treatment for “OFF” Episodes in Patients with Parkinson's Disease
**Background:** “On-demand” treatments approved in the United States (US) for “OFF” episodes in Parkinson’s disease (PD) include apomorphine hydrochloride injection (SC-APO), apomorphine sublingual film (APL), and levodopa inhalation powder (CVT-301). APL received US approval in 2020, and its cost-e...
Guardado en:
Autores principales: | Andrew Thach, Noam Kirson, Miriam L. Zichlin, Ibrahima Dieye, Eric Pappert, G. Rhys Williams |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Columbia Data Analytics, LLC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5f68444c1634208b50b603887e8c7cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cost-Effectiveness of Apomorphine Sublingual Film as an “On-Demand” Treatment for “OFF” Episodes in Patients with Parkinson's Disease
por: Andrew Thach, et al.
Publicado: (2021) -
Crowdsourcing digital health measures to predict Parkinson’s disease severity: the Parkinson’s Disease Digital Biomarker DREAM Challenge
por: Solveig K. Sieberts, et al.
Publicado: (2021) -
Facial expressions can detect Parkinson’s disease: preliminary evidence from videos collected online
por: Mohammad Rafayet Ali, et al.
Publicado: (2021) -
mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson’s disease
por: M. Kelley Erb, et al.
Publicado: (2020) -
Machine learning-based prediction of COVID-19 diagnosis based on symptoms
por: Yazeed Zoabi, et al.
Publicado: (2021)